-
1
-
-
3042694117
-
Large-scale meta-Analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
-
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM: Large-scale meta-Analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 2004, 101:9309-9314.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 9309-9314
-
-
Rhodes, D.R.1
Yu, J.2
Shanker, K.3
Deshpande, N.4
Varambally, R.5
Ghosh, D.6
Barrette, T.7
Pandey, A.8
Chinnaiyan, A.M.9
-
2
-
-
6944244084
-
A module map showing conditional activity of expression modules in cancer
-
Segal E, Friedman N, Koller D, Regev A: A module map showing conditional activity of expression modules in cancer. Nat Genet 2004, 36:1090-1098.
-
(2004)
Nat Genet
, vol.36
, pp. 1090-1098
-
-
Segal, E.1
Friedman, N.2
Koller, D.3
Regev, A.4
-
3
-
-
33751208636
-
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
-
Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS: Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A 2006, 103:17402-17407.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 17402-17407
-
-
Horvath, S.1
Zhang, B.2
Carlson, M.3
Lu, K.V.4
Zhu, S.5
Felciano, R.M.6
Laurance, M.F.7
Zhao, W.8
Qi, S.9
Chen, Z.10
Lee, Y.11
Scheck, A.C.12
Liau, L.M.13
Wu, H.14
Geschwind, D.H.15
Febbo, P.G.16
Kornblum, H.I.17
Cloughesy, T.F.18
Nelson, S.F.19
Mischel, P.S.20
more..
-
4
-
-
9144264883
-
In silico dissection of cell-Type-Associated patterns of gene expression in prostate cancer
-
Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L, Klacansky I, Masys D, Arden K, Goodison S, McClelland M, Wang Y, Sawyers A, Kalcheva I, Tarin D, Mercola D: In silico dissection of cell-Type-Associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci USA 2004, 101:615-620.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 615-620
-
-
Stuart, R.O.1
Wachsman, W.2
Berry, C.C.3
Wang-Rodriguez, J.4
Wasserman, L.5
Klacansky, I.6
Masys, D.7
Arden, K.8
Goodison, S.9
McClelland, M.10
Wang, Y.11
Sawyers, A.12
Kalcheva, I.13
Tarin, D.14
Mercola, D.15
-
5
-
-
33845884027
-
Integrative molecular concept modeling of prostate cancer progression
-
Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM: Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2007, 39:41-51.
-
(2007)
Nat Genet
, vol.39
, pp. 41-51
-
-
Tomlins, S.A.1
Mehra, R.2
Rhodes, D.R.3
Cao, X.4
Wang, L.5
Dhanasekaran, S.M.6
Kalyana-Sundaram, S.7
Wei, J.T.8
Rubin, M.A.9
Pienta, K.J.10
Shah, R.B.11
Chinnaiyan, A.M.12
-
6
-
-
0037226593
-
A molecular signature of metastasis in primary solid tumors
-
Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54.
-
(2003)
Nat Genet
, vol.33
, pp. 49-54
-
-
Ramaswamy, S.1
Ross, K.N.2
Lander, E.S.3
Golub, T.R.4
-
7
-
-
84942484786
-
Ridge regression: Biased estimation for nonorthogonal problems
-
Hoerl AE, Kennard RW: Ridge regression: Biased estimation for nonorthogonal problems. Technometrics 1970, 12:55-67.
-
(1970)
Technometrics
, vol.12
, pp. 55-67
-
-
Hoerl, A.E.1
Kennard, R.W.2
-
8
-
-
27644506613
-
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
-
Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM: Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005, 8:393-406.
-
(2005)
Cancer Cell
, vol.8
, pp. 393-406
-
-
Varambally, S.1
Yu, J.2
Laxman, B.3
Rhodes, D.R.4
Mehra, R.5
Tomlins, S.A.6
Shah, R.B.7
Chandran, U.8
Monzon, F.A.9
Becich, M.J.10
Wei, J.T.11
Pienta, K.J.12
Ghosh, D.13
Rubin, M.A.14
Chinnaiyan, A.M.15
-
9
-
-
84944178665
-
Hierarchical grouping to optimize an objective function
-
Ward JH Jr: Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963, 58:236-244.
-
(1963)
J Am Stat Assoc
, vol.58
, pp. 236-244
-
-
Ward, J.H.1
-
10
-
-
0001179368
-
Similarity analysis by reciprocal pairs for discrete and continuous data
-
McQuitty LL: Similarity analysis by reciprocal pairs for discrete and continuous data. Educ Psychol Measure 1966, 26:825-831.
-
(1966)
Educ Psychol Measure
, vol.26
, pp. 825-831
-
-
McQuitty, L.L.1
-
11
-
-
84940644968
-
A mathematical theory of communication
-
Shannon CE: A mathematical theory of communication. Bell Syst Tech J 1948, 27:379-423.
-
(1948)
Bell Syst Tech J
, vol.27
, pp. 379-423
-
-
Shannon, C.E.1
-
12
-
-
77953528177
-
On the interplay between entropy and robustness of gene regulatory networks
-
Chen B-S, Li C-W: On the interplay between entropy and robustness of gene regulatory networks. Entropy 2010, 12:1071-1101.
-
(2010)
Entropy
, vol.12
, pp. 1071-1101
-
-
Chen, B.-S.1
Li, C.-W.2
-
13
-
-
2942602999
-
Entropy-based gene ranking without selection bias for the predictive classification of microarray data
-
Furlanello C, Serafini M, Merler S, Jurman G: Entropy-based gene ranking without selection bias for the predictive classification of microarray data. BMC Bioinformatics 2003, 4:54.
-
(2003)
BMC Bioinformatics
, vol.4
, pp. 54
-
-
Furlanello, C.1
Serafini, M.2
Merler, S.3
Jurman, G.4
-
14
-
-
79952042778
-
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study
-
Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE, Mesher D, Speights VO, Stankiewicz E, Foster CS, Moller H, Scardino P, Warren JD, Park J, Younus A, Flake DD 2nd, Wagner S, Gutin A, Lanchbury JS, Stone S, Transatlantic Prostate G: Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study. Lancet Oncol 2011, 12:245-255.
-
(2011)
Lancet Oncol
, vol.12
, pp. 245-255
-
-
Cuzick, J.1
Swanson, G.P.2
Fisher, G.3
Brothman, A.R.4
Berney, D.M.5
Reid, J.E.6
Mesher, D.7
Speights, V.O.8
Stankiewicz, E.9
Foster, C.S.10
Moller, H.11
Scardino, P.12
Warren, J.D.13
Park, J.14
Younus, A.15
Flake, D.D.16
Wagner, S.17
Gutin, A.18
Lanchbury, J.S.19
Stone, S.20
Transatlantic, P.G.21
more..
-
15
-
-
84869220602
-
Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer
-
Fukuma Y, Matsui H, Koike H, Sekine Y, Shechter I, Ohtake N, Nakata S, Ito K, Suzuki K: Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer. Prostate Cancer Prostatic Dis 2012, 15:339-345.
-
(2012)
Prostate Cancer Prostatic Dis
, vol.15
, pp. 339-345
-
-
Fukuma, Y.1
Matsui, H.2
Koike, H.3
Sekine, Y.4
Shechter, I.5
Ohtake, N.6
Nakata, S.7
Ito, K.8
Suzuki, K.9
-
16
-
-
84862777506
-
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
-
Cuzick J, Berney DM, Fisher G, Mesher D, Moller H, Reid JE, Perry M, Park J, Younus A, Gutin A, Foster CS, Scardino P, Lanchbury JS, Stone S: Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer 2012, 106:1095-1099.
-
(2012)
Br J Cancer
, vol.106
, pp. 1095-1099
-
-
Cuzick, J.1
Berney, D.M.2
Fisher, G.3
Mesher, D.4
Moller, H.5
Reid, J.E.6
Perry, M.7
Park, J.8
Younus, A.9
Gutin, A.10
Foster, C.S.11
Scardino, P.12
Lanchbury, J.S.13
Stone, S.14
-
17
-
-
84901827161
-
Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
-
Yuan X, Cai C, Chen S, Yu Z, Balk SP: Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis. Oncogene 2014, 33:2815-2825.
-
(2014)
Oncogene
, vol.33
, pp. 2815-2825
-
-
Yuan, X.1
Cai, C.2
Chen, S.3
Yu, Z.4
Balk, S.P.5
-
18
-
-
0031059179
-
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
-
Jenkins RB, Qian J, Lieber MM, Bostwick DG: Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997, 57:524-531.
-
(1997)
Cancer Res
, vol.57
, pp. 524-531
-
-
Jenkins, R.B.1
Qian, J.2
Lieber, M.M.3
Bostwick, D.G.4
-
19
-
-
0141569009
-
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
-
Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL: Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003, 4:223-238.
-
(2003)
Cancer Cell
, vol.4
, pp. 223-238
-
-
Ellwood-Yen, K.1
Graeber, T.G.2
Wongvipat, J.3
Iruela-Arispe, M.L.4
Zhang, J.5
Matusik, R.6
Thomas, G.V.7
Sawyers, C.L.8
-
20
-
-
20444406861
-
Fibromodulin, an extracellular matrix protein: Characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
-
Mikaelsson E, Danesh-Manesh AH, Luppert A, Jeddi-Tehrani M, Rezvany MR, Sharifian RA, Safaie R, Roohi A, Osterborg A, Shokri F, Mellstedt H, Rabbani H: Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood 2005, 105:4828-4835.
-
(2005)
Blood
, vol.105
, pp. 4828-4835
-
-
Mikaelsson, E.1
Danesh-Manesh, A.H.2
Luppert, A.3
Jeddi-Tehrani, M.4
Rezvany, M.R.5
Sharifian, R.A.6
Safaie, R.7
Roohi, A.8
Osterborg, A.9
Shokri, F.10
Mellstedt, H.11
Rabbani, H.12
-
21
-
-
0038481230
-
The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays
-
Vallat L, Magdelenat H, Merle-Beral H, Masdehors P, Potocki De Montalk G, Davi F, Kruhoffer M, Sabatier L, Orntoft TF, Delic J: The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood 2003, 101:4598-4606.
-
(2003)
Blood
, vol.101
, pp. 4598-4606
-
-
Vallat, L.1
Magdelenat, H.2
Merle-Beral, H.3
Masdehors, P.4
Potocki De Montalk, G.5
Davi, F.6
Kruhoffer, M.7
Sabatier, L.8
Orntoft, T.F.9
Delic, J.10
-
22
-
-
24344447877
-
Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropinreleasing hormone analogue therapy and TGF-beta through smad and MAPK-mediated signalling
-
Levens E, Luo X, Ding L, Williams RS, Chegini N: Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropinreleasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Mol Hum Reprod 2005, 11:489-494.
-
(2005)
Mol Hum Reprod
, vol.11
, pp. 489-494
-
-
Levens, E.1
Luo, X.2
Ding, L.3
Williams, R.S.4
Chegini, N.5
-
23
-
-
68449103256
-
An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation
-
Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP: An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 2009, 8:2420-2424.
-
(2009)
Cell Cycle
, vol.8
, pp. 2420-2424
-
-
Di Vizio, D.1
Morello, M.2
Sotgia, F.3
Pestell, R.G.4
Freeman, M.R.5
Lisanti, M.P.6
-
24
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL: Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22.
-
(2010)
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
Gopalan, A.4
Xiao, Y.5
Carver, B.S.6
Arora, V.K.7
Kaushik, P.8
Cerami, E.9
Reva, B.10
Antipin, Y.11
Mitsiades, N.12
Landers, T.13
Dolgalev, I.14
Major, J.E.15
Wilson, M.16
Socci, N.D.17
Lash, A.E.18
Heguy, A.19
Eastham, J.A.20
Scher, H.I.21
Reuter, V.E.22
Scardino, P.T.23
Sander, C.24
Sawyers, C.L.25
Gerald, W.L.26
more..
-
25
-
-
1642377561
-
ONCOMINE: A cancer microarray database and integrated data-mining platform
-
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM: ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6.
-
(2004)
Neoplasia
, vol.6
, pp. 1-6
-
-
Rhodes, D.R.1
Yu, J.2
Shanker, K.3
Deshpande, N.4
Varambally, R.5
Ghosh, D.6
Barrette, T.7
Pandey, A.8
Chinnaiyan, A.M.9
-
26
-
-
84942594259
-
UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation
-
Advance online publication 22nd September
-
Itkonen HM, Engedal N, Babaie E, Luhr M, Guldvik IJ, Minner S, Hohloch J, Tsourlakis MC, Schlomm T, Mills IG: UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation. Oncogene 2014. Advance online publication 22nd September; doi:10.1038/onc.2014.307.
-
(2014)
Oncogene
-
-
Itkonen, H.M.1
Engedal, N.2
Babaie, E.3
Luhr, M.4
Guldvik, I.J.5
Minner, S.6
Hohloch, J.7
Tsourlakis, M.C.8
Schlomm, T.9
Mills, I.G.10
-
27
-
-
27244458790
-
Expression of core 2 beta1, 6-N-Acetylglucosaminyltransferase facilitates prostate cancer progression
-
Hagisawa S, Ohyama C, Takahashi T, Endoh M, Moriya T, Nakayama J, Arai Y, Fukuda M: Expression of core 2 beta1, 6-N-Acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology 2005, 15:1016-1024.
-
(2005)
Glycobiology
, vol.15
, pp. 1016-1024
-
-
Hagisawa, S.1
Ohyama, C.2
Takahashi, T.3
Endoh, M.4
Moriya, T.5
Nakayama, J.6
Arai, Y.7
Fukuda, M.8
-
28
-
-
84896756738
-
Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers
-
Ma W, Diep K, Fritsche HA, Shore N, Albitar M: Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers. Genet Test Mol Biomarkers 2014, 18:156-163.
-
(2014)
Genet Test Mol Biomarkers
, vol.18
, pp. 156-163
-
-
Ma, W.1
Diep, K.2
Fritsche, H.A.3
Shore, N.4
Albitar, M.5
-
29
-
-
84894076239
-
Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients
-
Kamigaito T, Okaneya T, Kawakubo M, Shimojo H, Nishizawa O, Nakayama J: Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients. Prostate Cancer Prostatic Dis 2014, 17:18-22.
-
(2014)
Prostate Cancer Prostatic Dis
, vol.17
, pp. 18-22
-
-
Kamigaito, T.1
Okaneya, T.2
Kawakubo, M.3
Shimojo, H.4
Nishizawa, O.5
Nakayama, J.6
-
30
-
-
84882607514
-
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells
-
Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T, Mills IG: O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res 2013, 73:5277-5287.
-
(2013)
Cancer Res
, vol.73
, pp. 5277-5287
-
-
Itkonen, H.M.1
Minner, S.2
Guldvik, I.J.3
Sandmann, M.J.4
Tsourlakis, M.C.5
Berge, V.6
Svindland, A.7
Schlomm, T.8
Mills, I.G.9
-
31
-
-
50249133616
-
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
-
Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C, Hicks JL, Morgan J, Cornish TC, Sutcliffe S, Isaacs WB, Luo J, De Marzo AM: Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 2008, 21:1156-1167.
-
(2008)
Mod Pathol
, vol.21
, pp. 1156-1167
-
-
Gurel, B.1
Iwata, T.2
Koh, C.M.3
Jenkins, R.B.4
Lan, F.5
Van, D.C.6
Hicks, J.L.7
Morgan, J.8
Cornish, T.C.9
Sutcliffe, S.10
Isaacs, W.B.11
Luo, J.12
De Marzo, A.M.13
-
32
-
-
0029049198
-
C-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas
-
Chou TY, Hart GW, Dang CV: C-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 1995, 270:18961-18965.
-
(1995)
J Biol Chem
, vol.270
, pp. 18961-18965
-
-
Chou, T.Y.1
Hart, G.W.2
Dang, C.V.3
-
33
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648.
-
(2005)
Science
, vol.310
, pp. 644-648
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
Dhanasekaran, S.M.4
Mehra, R.5
Sun, X.W.6
Varambally, S.7
Cao, X.8
Tchinda, J.9
Kuefer, R.10
Lee, C.11
Montie, J.E.12
Shah, R.B.13
Pienta, K.J.14
Rubin, M.A.15
Chinnaiyan, A.M.16
-
34
-
-
0036870701
-
Down's syndrome-Associated single minded gene as a novel tumor marker
-
Deyoung MP, Scheurle D, Damania H, Zylberberg C, Narayanan R: Down's syndrome-Associated single minded gene as a novel tumor marker. Anticancer Res 2002, 22:3149-3157.
-
(2002)
Anticancer Res
, vol.22
, pp. 3149-3157
-
-
Deyoung, M.P.1
Scheurle, D.2
Damania, H.3
Zylberberg, C.4
Narayanan, R.5
-
35
-
-
33847396441
-
Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer
-
Halvorsen OJ, Rostad K, Oyan AM, Puntervoll H, Bo TH, Stordrange L, Olsen S, Haukaas SA, Hood L, Jonassen I, Kalland KH, Akslen LA: Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer. Clin Cancer Res 2007, 13:892-897.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 892-897
-
-
Halvorsen, O.J.1
Rostad, K.2
Oyan, A.M.3
Puntervoll, H.4
Bo, T.H.5
Stordrange, L.6
Olsen, S.7
Haukaas, S.A.8
Hood, L.9
Jonassen, I.10
Kalland, K.H.11
Akslen, L.A.12
-
36
-
-
79953645458
-
Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene
-
Koh CM, Gurel B, Sutcliffe S, Aryee MJ, Schultz D, Iwata T, Uemura M, Zeller KI, Anele U, Zheng Q, Hicks JL, Nelson WG, Dang CV, Yegnasubramanian S, De Marzo AM: Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. Am J Pathol 2011, 178:1824-1834.
-
(2011)
Am J Pathol
, vol.178
, pp. 1824-1834
-
-
Koh, C.M.1
Gurel, B.2
Sutcliffe, S.3
Aryee, M.J.4
Schultz, D.5
Iwata, T.6
Uemura, M.7
Zeller, K.I.8
Anele, U.9
Zheng, Q.10
Hicks, J.L.11
Nelson, W.G.12
Dang, C.V.13
Yegnasubramanian, S.14
De Marzo, A.M.15
-
37
-
-
84897028090
-
ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells
-
Wang L, Li Y, Yang X, Yuan H, Li X, Qi M, Chang YW, Wang C, Fu W, Yang M, Zhang J, Han B: ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells. Prostate 2014, 74:647-658.
-
(2014)
Prostate
, vol.74
, pp. 647-658
-
-
Wang, L.1
Li, Y.2
Yang, X.3
Yuan, H.4
Li, X.5
Qi, M.6
Chang, Y.W.7
Wang, C.8
Fu, W.9
Yang, M.10
Zhang, J.11
Han, B.12
-
38
-
-
79959829839
-
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model
-
Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R: TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. Plos One 2011, 6:e21650.
-
(2011)
Plos One
, vol.6
, pp. e21650
-
-
Leshem, O.1
Madar, S.2
Kogan-Sakin, I.3
Kamer, I.4
Goldstein, I.5
Brosh, R.6
Cohen, Y.7
Jacob-Hirsch, J.8
Ehrlich, M.9
Ben-Sasson, S.10
Goldfinger, N.11
Loewenthal, R.12
Gazit, E.13
Rotter, V.14
Berger, R.15
-
39
-
-
79960632568
-
Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene
-
Ribeiro FR, Paulo P, Costa VL, Barros-Silva JD, Ramalho-Carvalho J, Jeronimo C, Henrique R, Lind GE, Skotheim RI, Lothe RA, Teixeira MR: Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene. Plos One 2011, 6:e22317.
-
(2011)
Plos One
, vol.6
, pp. e22317
-
-
Ribeiro, F.R.1
Paulo, P.2
Costa, V.L.3
Barros-Silva, J.D.4
Ramalho-Carvalho, J.5
Jeronimo, C.6
Henrique, R.7
Lind, G.E.8
Skotheim, R.I.9
Lothe, R.A.10
Teixeira, M.R.11
-
40
-
-
84878444703
-
N-linked glycosylation supports cross-Talk between receptor tyrosine kinases and androgen receptor
-
Itkonen HM, Mills IG: N-linked glycosylation supports cross-Talk between receptor tyrosine kinases and androgen receptor. Plos One 2013, 8:e65016.
-
(2013)
Plos One
, vol.8
, pp. e65016
-
-
Itkonen, H.M.1
Mills, I.G.2
-
41
-
-
0028944138
-
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
-
Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995, 9:401-406.
-
(1995)
Nat Genet
, vol.9
, pp. 401-406
-
-
Visakorpi, T.1
Hyytinen, E.2
Koivisto, P.3
Tanner, M.4
Keinanen, R.5
Palmberg, C.6
Palotie, A.7
Tammela, T.8
Isola, J.9
Kallioniemi, O.P.10
-
42
-
-
79961222799
-
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
-
94ra72
-
Tomlins SA, Aubin SM, Siddiqui J, Lonigro RJ, Sefton-Miller L, Miick S, Williamsen S, Hodge P, Meinke J, Blase A, Penabella Y, Day JR, Varambally R, Han B, Wood D, Wang L, Sanda MG, Rubin MA, Rhodes DR, Hollenbeck B, Sakamoto K, Silberstein JL, Fradet Y, Amberson JB, Meyers S, Palanisamy N, Rittenhouse H, Wei JT, Groskopf J, Chinnaiyan AM: Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med 2011, 3:94ra72.
-
(2011)
Sci Transl Med
, vol.3
-
-
Tomlins, S.A.1
Aubin, S.M.2
Siddiqui, J.3
Lonigro, R.J.4
Sefton-Miller, L.5
Miick, S.6
Williamsen, S.7
Hodge, P.8
Meinke, J.9
Blase, A.10
Penabella, Y.11
Day, J.R.12
Varambally, R.13
Han, B.14
Wood, D.15
Wang, L.16
Sanda, M.G.17
Rubin, M.A.18
Rhodes, D.R.19
Hollenbeck, B.20
Sakamoto, K.21
Silberstein, J.L.22
Fradet, Y.23
Amberson, J.B.24
Meyers, S.25
Palanisamy, N.26
Rittenhouse, H.27
Wei, J.T.28
Groskopf, J.29
Chinnaiyan, A.M.30
more..
-
43
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA: The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012, 487:239-243.
-
(2012)
Nature
, vol.487
, pp. 239-243
-
-
Grasso, C.S.1
Wu, Y.M.2
Robinson, D.R.3
Cao, X.4
Dhanasekaran, S.M.5
Khan, A.P.6
Quist, M.J.7
Jing, X.8
Lonigro, R.J.9
Brenner, J.C.10
Asangani, I.A.11
Ateeq, B.12
Chun, S.Y.13
Siddiqui, J.14
Sam, L.15
Anstett, M.16
Mehra, R.17
Prensner, J.R.18
Palanisamy, N.19
Ryslik, G.A.20
Vandin, F.21
Raphael, B.J.22
Kunju, L.P.23
Rhodes, D.R.24
Pienta, K.J.25
Chinnaiyan, A.M.26
Tomlins, S.A.27
more..
-
44
-
-
84921984191
-
Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers
-
Fleischmann A, Saramaki OR, Zlobec I, Rotzer D, Genitsch V, Seiler R, Visakorpi T, Thalmann GN: Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers. Prostate 2014, 74:1647-1654.
-
(2014)
Prostate
, vol.74
, pp. 1647-1654
-
-
Fleischmann, A.1
Saramaki, O.R.2
Zlobec, I.3
Rotzer, D.4
Genitsch, V.5
Seiler, R.6
Visakorpi, T.7
Thalmann, G.N.8
-
45
-
-
33847105565
-
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression
-
Nam RK, Sugar L, Wang Z, Yang W, Kitching R, Klotz LH, Venkateswaran V, Narod SA, Seth A: Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 2007, 6:40-45.
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 40-45
-
-
Nam, R.K.1
Sugar, L.2
Wang, Z.3
Yang, W.4
Kitching, R.5
Klotz, L.H.6
Venkateswaran, V.7
Narod, S.A.8
Seth, A.9
-
46
-
-
50349102353
-
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
-
Saramaki OR, Harjula AE, Martikainen PM, Vessella RL, Tammela TL, Visakorpi T: TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. Clin Cancer Res 2008, 14:3395-3400.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3395-3400
-
-
Saramaki, O.R.1
Harjula, A.E.2
Martikainen, P.M.3
Vessella, R.L.4
Tammela, T.L.5
Visakorpi, T.6
|